Showing results (331-340 of 489) with videos related to

Sort By:
Pageof 49
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|May 12, 2011
A new perspective on optimal care for patients with COPDDirkje Postma, Antonio Anzueto, Peter Calverley, et al.
The Clinical Respiratory Journal|December 17, 2010
Bias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH studyJørgen Vestbo, Julie Anne Anderson, Peter Mark Anthony Calverley, et al.
Chest|June 26, 2010
Reported pneumonia in patients with COPD: findings from the INSPIRE studyPeter M A Calverley, Robert A Stockley, Terence A R Seemungal, et al.
Annals of the American Thoracic Society|August 18, 2021
Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFTNirupama Putcha, Antonio R Anzueto, Peter M A Calverley, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 29, 2022
The Effect of Maintenance Treatment with Erdosteine on Exacerbation Treatment and Health Status in Patients with COPD: A Post-Hoc Analysis of the RESTORE DatasetPeter M A Calverley, Alberto Papi, Clive Page, et al.
American Journal of Respiratory Cell and Molecular Biology|March 17, 2007
Haemophilus influenzae induces neutrophil necrosis: a role in chronic obstructive pulmonary disease?Emma J Naylor, Denise Bakstad, Mark Biffen, et al.
Respiratory Research|April 4, 2013
The Tiotropium Safety and Performance in Respimat Trial (TIOSPIR), a large scale, randomized, controlled, parallel-group trial-design and rationaleRobert A Wise, Antonio Anzueto, Peter Calverley, et al.
The European Respiratory Journal|November 3, 2009
Methods for therapeutic trials in COPD: lessons from the TORCH trialO N Keene, J Vestbo, J A Anderson, et al.
Advances in Therapy|August 11, 2020
Tiotropium/Olodaterol Decreases Exacerbation Rates Compared with Tiotropium in a Range of Patients with COPD: Pooled Analysis of the TONADO®/DYNAGITO® TrialsJadwiga A Wedzicha, Roland Buhl, Dave Singh, et al.
Clinical Immunology (Orlando, Fla.)|June 15, 2007
A unique T cell subset described as CD4loCD40+ T cells (TCD40) in human type 1 diabetesDan M Waid, Rebecca J Wagner, Amy Putnam, et al.
Pageof 49